Celecoxib 400 mg

DRUG5 trials

Sponsors

Iroko Pharmaceuticals, LLC, Rush University Medical Center, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Stony Brook University

Conditions

Dental PainMajor Depressive DisorderMetastatic CancerNeuroinflammationOpioid UseShoulder Pain

Phase 2

Phase 2 Study of Indomethacin Capsules to Treat Dental Pain

CompletedNCT00964431

Iroko Pharmaceuticals, LLCDental Pain

Start: 2009-08-31End: 2009-12-31Updated: 2012-05-22

Study of Diclofenac Capsules to Treat Dental Pain

CompletedNCT00985439

Iroko Pharmaceuticals, LLCDental Pain

Start: 2009-09-30End: 2009-12-31Updated: 2012-05-22

An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced Cold Solid Tumors

Cliniques universitaires Saint-Luc- Université Catholique de LouvainMetastatic Cancer

Start: 2019-08-15End: 2021-06-15Target: 68Updated: 2019-07-12

Phase 3

Multimodal Analgesia in Shoulder Arthroplasty

WithdrawnNCT03586934

Rush University Medical CenterOpioid Use, Shoulder Pain

Start: 2018-06-01End: 2019-06-01Updated: 2021-09-28

Phase 4

The Effect of Celecoxib on Neuroinflammation in MDD

Active, not recruitingNCT04814355

Stony Brook UniversityMajor Depressive Disorder, Neuroinflammation

Start: 2018-08-01End: 2026-02-28Target: 42Updated: 2025-08-29

Related Papers

A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac.

2012-10-0820 citations